Aktiesnakken — Juni 2013
-
nn siger 1067167
-
Solsen QCOR i 51
-
+40% I premarket
-
Nordea´s eftermiddagskommentar til Genmab "Genmab falder kraftigt tilbage efter at en større investor har solgt sin aktiepost
på over 5% af selskabet. Vi ser tilbagefaldet som en overreaktion, og anbefaler
risikovillige investorer til at samle aktien op. Nordea Markets anbefaling lyder på
Stærkt Køb med et kursmål på ca. 40% over dagens kurs."
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind